228 related articles for article (PubMed ID: 28768662)
1. Stimulation of diuresis and natriuresis by renomedullary infusion of a dual inhibitor of fatty acid amide hydrolase and monoacylglycerol lipase.
Ahmad A; Daneva Z; Li G; Dempsey SK; Li N; Poklis JL; Lichtman A; Li PL; Ritter JK
Am J Physiol Renal Physiol; 2017 Nov; 313(5):F1068-F1076. PubMed ID: 28768662
[TBL] [Abstract][Full Text] [Related]
2. Modulation of mean arterial pressure and diuresis by renomedullary infusion of a selective inhibitor of fatty acid amide hydrolase.
Ahmad A; Dempsey SK; Daneva Z; Li N; Poklis JL; Li PL; Ritter JK
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F967-F976. PubMed ID: 29846106
[TBL] [Abstract][Full Text] [Related]
3. Production and actions of the anandamide metabolite prostamide E2 in the renal medulla.
Ritter JK; Li C; Xia M; Poklis JL; Lichtman AH; Abdullah RA; Dewey WL; Li PL
J Pharmacol Exp Ther; 2012 Sep; 342(3):770-9. PubMed ID: 22685343
[TBL] [Abstract][Full Text] [Related]
4. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s).
Suzuki H; Ito Y; Noro Y; Koketsu M; Kamijima M; Tomizawa M
Toxicol Lett; 2014 Feb; 225(1):153-7. PubMed ID: 24361246
[TBL] [Abstract][Full Text] [Related]
5. Diuretic, Natriuretic, and Vasodepressor Activity of a Lipid Fraction Enhanced in Medium of Cultured Mouse Medullary Interstitial Cells by a Selective Fatty Acid Amide Hydrolase Inhibitor.
Daneva Z; Dempsey SK; Ahmad A; Li N; Li PL; Ritter JK
J Pharmacol Exp Ther; 2019 Feb; 368(2):187-198. PubMed ID: 30530623
[TBL] [Abstract][Full Text] [Related]
6. Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Pryce G; Cabranes A; Fernández-Ruiz J; Bisogno T; Di Marzo V; Long JZ; Cravatt BF; Giovannoni G; Baker D
Mult Scler; 2013 Dec; 19(14):1896-904. PubMed ID: 23625705
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Diuresis and Natriuresis by Cannabinoids: Evidence for Inhibition of Na
Ritter JK; Ahmad A; Mummalaneni S; Daneva Z; Dempsey SK; Li N; Li PL; Lyall V
J Pharmacol Exp Ther; 2021 Jan; 376(1):1-11. PubMed ID: 33087396
[TBL] [Abstract][Full Text] [Related]
8. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
Panlilio LV; Thorndike EB; Nikas SP; Alapafuja SO; Bandiera T; Cravatt BF; Makriyannis A; Piomelli D; Goldberg SR; Justinova Z
Psychopharmacology (Berl); 2016 May; 233(10):1879-88. PubMed ID: 26558620
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
11. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
Glaser ST; Gatley SJ; Gifford AN
J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
[TBL] [Abstract][Full Text] [Related]
16. Differential mechanisms mediating depressor and diuretic effects of anandamide.
Li J; Wang DH
J Hypertens; 2006 Nov; 24(11):2271-6. PubMed ID: 17053550
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576
[TBL] [Abstract][Full Text] [Related]
18. The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review.
Fowler CJ
Handb Exp Pharmacol; 2015; 231():95-128. PubMed ID: 26408159
[TBL] [Abstract][Full Text] [Related]
19. Chemical probes of endocannabinoid metabolism.
Blankman JL; Cravatt BF
Pharmacol Rev; 2013 Apr; 65(2):849-71. PubMed ID: 23512546
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]